(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WUXILIAB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

WUXILIAB

ST13

US500000097932171

Class

42

Filing

97932171

Registration

7430458

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

06/25/2024

Trademark type

Word

Nice classes

42

Filing date

05/11/2023

Registration date

06/25/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/25/2024

Last transaction

06/25/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2023-04-00

First use in commerce

2023-04-00

Drawing code

4

Owner type

99

Owner location

DUNDALK, CO LOUTH, IE

Examiner

GEARHART, JESSICA

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

WUXI BIOLOGICS IRELAND LIMITED

Representatives

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH, LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of antibodies; DNA screening for scientific research purposes; structural and functional analysis of genomes; Genetic screening for scientific purposes; Genetic testing for scientific research; pharmaceutical drug development services; pharmaceutical research; pharmaceutical research and development; pharmaceutical research services; Scientific research; scientific research services and new product development in the field of monoclonal antibodies; product development for others; research and development of new products; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/25/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/25/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/22/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/22/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/17/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/17/2024

IUAF

USE AMENDMENT FILED

02/22/2024

EISU

TEAS STATEMENT OF USE RECEIVED

02/22/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/12/2023

PUBO

PUBLISHED FOR OPPOSITION

12/12/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/22/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/07/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

11/07/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/07/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

11/07/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/07/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/12/2023

GNRT

NON-FINAL ACTION E-MAILED

10/12/2023

CNRT

NON-FINAL ACTION WRITTEN

10/12/2023

DOCK

ASSIGNED TO EXAMINER

10/03/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/16/2023

NWAP

NEW APPLICATION ENTERED

05/15/2023

Continuous trademark protection

Get notified about every new filing that threatens WUXILIAB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.